Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Intuitive Surgical Inc (ISRG) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Intuitive Surgical Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1035267.
Total stock buying since 2015: $0.
Total stock sales since 2015: $1,434,333,338.
Total stock option exercises since 2015: $424,612,649.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 0 | $0 | 28,315 | $15,011,804 | 35,580 | $4,628,434 |
| 2025 | 0 | $0 | 258,906 | $138,091,705 | 314,409 | $32,763,094 |
| 2024 | 0 | $0 | 423,641 | $177,762,397 | 531,276 | $50,282,277 |
| 2023 | 0 | $0 | 343,215 | $98,975,051 | 465,412 | $26,728,874 |
| 2022 | 0 | $0 | 175,089 | $39,031,468 | 309,859 | $18,059,668 |
| 2021 | 0 | $0 | 185,060 | $138,368,207 | 235,636 | $33,216,018 |
| 2020 | 0 | $0 | 200,043 | $121,851,158 | 216,309 | $25,792,434 |
| 2019 | 0 | $0 | 148,222 | $79,761,564 | 211,803 | $24,674,335 |
| 2018 | 0 | $0 | 495,013 | $236,137,167 | 491,954 | $34,900,403 |
| 2017 | 0 | $0 | 240,582 | $160,114,638 | 238,162 | $57,656,870 |
| 2016 | 0 | $0 | 181,415 | $113,758,674 | 191,978 | $57,410,295 |
| 2015 | 0 | $0 | 223,773 | $115,469,505 | 246,816 | $58,499,947 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-29 | Guthart Gary S (CEO) | Option Ex | 33,750 | 51.02 | 1,721,790 |
| 2024-01-26 | Curet Myriam (EVP & Chief Medical Officer) | Sale | 4,318 | 370.15 | 1,598,299 |
| 2024-01-26 | Curet Myriam (EVP & Chief Medical Officer) | Option Ex | 4,318 | 180.41 | 779,010 |
| 2024-01-26 | Johnson Amal M (Director) | Sale | 6,696 | 370.08 | 2,478,035 |
| 2024-01-26 | Johnson Amal M (Director) | Option Ex | 6,696 | 56.97 | 381,497 |
| 2024-01-26 | Levy Alan J (Director) | Sale | 2,000 | 370.20 | 740,404 |
| 2024-01-26 | Levy Alan J (Director) | Option Ex | 2,000 | 122.37 | 244,732 |
| 2023-11-16 | Curet Myriam (EVP & Chief Medical Officer) | Sale | 8,819 | 300.00 | 2,645,700 |
| 2023-11-16 | Curet Myriam (EVP & Chief Medical Officer) | Option Ex | 8,819 | 175.81 | 1,550,503 |
| 2023-11-16 | Johnson Amal M (Director) | Sale | 9,567 | 300.00 | 2,870,100 |
| 2023-11-16 | Johnson Amal M (Director) | Option Ex | 9,567 | 41.26 | 394,715 |
| 2023-11-14 | Desantis Robert (EVP & Chief Strategy & Corp Op) | Sale | 867 | 290.00 | 251,430 |
| 2023-11-14 | Desantis Robert (EVP & Chief Strategy & Corp Op) | Option Ex | 867 | 243.97 | 211,520 |
| 2023-11-14 | Levy Alan J (Director) | Sale | 2,000 | 290.00 | 580,000 |
| 2023-11-14 | Levy Alan J (Director) | Option Ex | 2,000 | 90.49 | 180,988 |
| 2023-10-26 | Guthart Gary S (CEO) | Sale | 27,385 | 260.11 | 7,123,030 |
| 2023-10-26 | Guthart Gary S (CEO) | Option Ex | 33,750 | 49.34 | 1,665,326 |
| 2023-10-24 | Desantis Robert (EVP & Chief Strategy & Corp Op) | Sale | 1,110 | 272.95 | 302,977 |
| 2023-10-24 | Desantis Robert (EVP & Chief Strategy & Corp Op) | Option Ex | 1,110 | 188.86 | 209,636 |
| 2023-10-24 | Guthart Gary S (CEO) | Sale | 4,960 | 271.93 | 1,348,772 |
| 2023-10-10 | Loeb Gary (General Counsel) | Option Ex | 2,613 | .00 | 0 |
| 2023-09-14 | Ladd Amy L (Director) | Sale | 500 | 305.68 | 152,840 |
| 2023-08-07 | Levy Alan J (Director) | Sale | 2,000 | 310.00 | 620,000 |
| 2023-08-07 | Levy Alan J (Director) | Option Ex | 2,000 | 80.91 | 161,818 |
| 2023-07-31 | Guthart Gary S (CEO) | Sale | 4,960 | 325.89 | 1,616,414 |
| 2023-07-28 | Guthart Gary S (CEO) | Sale | 50,314 | 326.76 | 16,440,753 |
| 2023-07-28 | Guthart Gary S (CEO) | Option Ex | 67,500 | 42.64 | 2,877,997 |
| 2023-07-25 | Desantis Robert (EVP & Chief Strategy & Corp Op) | Sale | 2,535 | 323.13 | 819,142 |
| 2023-07-25 | Desantis Robert (EVP & Chief Strategy & Corp Op) | Option Ex | 2,535 | 224.14 | 568,199 |
| 2023-06-14 | Desantis Robert (EVP & Chief Product Officer) | Sale | 2,443 | 325.00 | 793,975 |
| 2023-06-14 | Desantis Robert (EVP & Chief Product Officer) | Option Ex | 2,443 | 290.33 | 709,276 |
| 2023-06-14 | Barratt Craig H (Director) | Sale | 1,567 | 322.78 | 505,796 |
| 2023-06-14 | Barratt Craig H (Director) | Option Ex | 1,567 | 41.26 | 64,651 |
| 2023-06-14 | Mohr Marshall (Executive VP Global Business S) | Sale | 11,250 | 325.00 | 3,656,250 |
| 2023-06-14 | Mohr Marshall (Executive VP Global Business S) | Option Ex | 11,250 | 59.46 | 668,947 |
| 2023-05-11 | Desantis Robert (EVP & Chief Product Officer) | Option Ex | 363 | .00 | 0 |
| 2023-05-01 | Barratt Craig H (Director) | Sale | 2,000 | 306.00 | 612,000 |
| 2023-05-01 | Barratt Craig H (Director) | Option Ex | 2,000 | 41.26 | 82,516 |
| 2023-04-28 | Rubash Mark J (Director) | Sale | 7,323 | 300.00 | 2,196,900 |
| 2023-04-28 | Rubash Mark J (Director) | Option Ex | 7,323 | 169.93 | 1,244,419 |
| 2023-04-27 | Reed Monica P (Director) | Option Ex | 482 | .00 | 0 |
| 2023-04-27 | Ladd Amy L (Director) | Option Ex | 482 | .00 | 0 |
| 2023-04-27 | Leonard Keith R (Director) | Option Ex | 482 | .00 | 0 |
| 2023-04-27 | Johnson Amal M (Director) | Option Ex | 482 | .00 | 0 |
| 2023-04-27 | Levy Alan J (Director) | Option Ex | 482 | .00 | 0 |
| 2023-04-27 | Barratt Craig H (Director) | Option Ex | 655 | .00 | 0 |
| 2023-04-27 | Kania Don R (Director) | Option Ex | 482 | .00 | 0 |
| 2023-04-27 | Beery Joseph C (Director) | Option Ex | 482 | .00 | 0 |
| 2023-04-27 | Nachtsheim Jami K (Director) | Option Ex | 482 | .00 | 0 |
| 2023-04-27 | Rubash Mark J (Director) | Option Ex | 482 | .00 | 0 |
| 2023-04-24 | Rosa David J. (EVP Chief Strategy & Growth Of) | Sale | 40,764 | 299.20 | 12,196,466 |
| 2023-04-24 | Rosa David J. (EVP Chief Strategy & Growth Of) | Option Ex | 54,000 | 42.64 | 2,302,398 |
| 2023-04-21 | Widman Fredrik (VP Corporate Controller) | Sale | 630 | 297.87 | 187,658 |
| 2023-04-21 | Desantis Robert (EVP & Chief Product Officer) | Sale | 8,623 | 297.94 | 2,569,119 |
| 2023-04-21 | Desantis Robert (EVP & Chief Product Officer) | Option Ex | 6,260 | 210.91 | 1,320,265 |
| 2023-04-21 | Curet Myriam (EVP & Chief Medical Officer) | Sale | 9,623 | 299.48 | 2,881,896 |
| 2023-04-21 | Curet Myriam (EVP & Chief Medical Officer) | Option Ex | 8,000 | 170.44 | 1,363,520 |
| 2023-04-21 | Rosa David J. (EVP Chief Strategy & Growth Of) | Sale | 40,800 | 297.92 | 12,155,176 |
| 2023-04-21 | Rosa David J. (EVP Chief Strategy & Growth Of) | Option Ex | 54,000 | 42.64 | 2,302,398 |
| 2023-04-21 | Barratt Craig H (Director) | Sale | 6,000 | 297.92 | 1,787,526 |
| 2023-04-21 | Barratt Craig H (Director) | Option Ex | 6,000 | 41.26 | 247,548 |
| 2023-04-21 | Rubash Mark J (Director) | Sale | 9,818 | 297.92 | 2,925,051 |
| 2023-04-21 | Rubash Mark J (Director) | Option Ex | 9,818 | 113.02 | 1,353,841 |
| 2023-03-01 | Curet Myriam (EVP & Chief Medical Officer) | Sale | 1,253 | 228.47 | 286,272 |
| 2023-02-28 | Widman Fredrik (VP Corporate Controller) | Option Ex | 1,317 | .00 | 0 |
| 2023-02-28 | Charlton Henry L (Senior Vice President & Chief) | Option Ex | 2,201 | .00 | 0 |
| 2023-02-28 | Desantis Robert (EVP & Chief Product Officer) | Option Ex | 3,679 | .00 | 0 |
| 2023-02-28 | Curet Myriam (EVP & Chief Medical Officer) | Option Ex | 3,259 | .00 | 0 |
| 2023-02-28 | Rosa David J. (EVP Chief Strategy & Growth Of) | Option Ex | 3,760 | .00 | 0 |
| 2023-02-28 | Samath Jamie (Chief Financial Officer) | Option Ex | 2,009 | .00 | 0 |
| 2023-02-28 | Guthart Gary S (President & CEO) | Option Ex | 6,371 | .00 | 0 |
| 2023-02-28 | Mohr Marshall (Executive VP Global Business S) | Option Ex | 3,259 | .00 | 0 |
| 2023-02-26 | Widman Fredrik (VP Corporate Controller) | Option Ex | 609 | .00 | 0 |
| 2023-02-26 | Charlton Henry L (Senior Vice President & Chief) | Option Ex | 1,284 | .00 | 0 |
| 2023-02-26 | Desantis Robert (EVP & Chief Product Officer) | Option Ex | 1,590 | .00 | 0 |
| 2023-02-26 | Curet Myriam (EVP & Chief Medical Officer) | Option Ex | 1,710 | .00 | 0 |
| 2023-02-26 | Rosa David J. (EVP Chief Strategy & Growth Of) | Option Ex | 1,710 | .00 | 0 |
| 2023-02-26 | Samath Jamie (Chief Financial Officer) | Option Ex | 1,284 | .00 | 0 |
| 2023-02-26 | Guthart Gary S (President & CEO) | Option Ex | 3,030 | .00 | 0 |
| 2023-02-26 | Mohr Marshall (Executive VP Global Business S) | Option Ex | 1,710 | .00 | 0 |
| 2023-02-16 | Widman Fredrik (VP Corporate Controller) | Sale | 116 | 240.77 | 27,929 |
| 2023-02-16 | Desantis Robert (EVP & Chief Product Officer) | Sale | 1,971 | 240.77 | 474,557 |
| 2023-02-16 | Curet Myriam (EVP & Chief Medical Officer) | Sale | 1,124 | 240.77 | 270,625 |
| 2023-02-15 | Widman Fredrik (VP Corporate Controller) | Option Ex | 393 | .00 | 0 |
| 2023-02-15 | Charlton Henry L (Senior Vice President & Chief) | Option Ex | 1,311 | .00 | 0 |
| 2023-02-15 | Desantis Robert (EVP & Chief Product Officer) | Option Ex | 2,124 | .00 | 0 |
| 2023-02-15 | Curet Myriam (EVP & Chief Medical Officer) | Option Ex | 1,749 | .00 | 0 |
| 2023-02-15 | Rosa David J. (EVP Chief Strategy & Growth Of) | Option Ex | 2,250 | .00 | 0 |
| 2023-02-15 | Samath Jamie (Chief Financial Officer) | Option Ex | 723 | .00 | 0 |
| 2023-02-15 | Guthart Gary S (President & CEO) | Option Ex | 3,750 | .00 | 0 |
| 2023-02-15 | Mohr Marshall (Executive VP Global Business S) | Option Ex | 1,749 | .00 | 0 |
| 2023-02-13 | Widman Fredrik (VP Corporate Controller) | Sale | 1,307 | 246.09 | 321,639 |
| 2023-02-13 | Mohr Marshall (Executive VP Global Business S) | Sale | 33,249 | 245.61 | 8,166,386 |
| 2023-02-13 | Mohr Marshall (Executive VP Global Business S) | Option Ex | 54,000 | 63.25 | 3,415,284 |
| 2023-02-10 | Dimartino Michele (See Remarks) | Option Ex | 2,491 | .00 | 0 |
| 2023-02-06 | Rosa David J. (EVP Chief Strategy & Growth Of) | Sale | 45,025 | 250.53 | 11,280,023 |
| 2023-02-06 | Rosa David J. (EVP Chief Strategy & Growth Of) | Option Ex | 54,000 | 63.25 | 3,415,284 |
| 2023-01-27 | Desantis Robert (EVP & Chief Product Officer) | Sale | 1,629 | 250.00 | 407,250 |
| 2023-01-27 | Desantis Robert (EVP & Chief Product Officer) | Option Ex | 1,629 | 178.84 | 291,335 |
| 2022-11-01 | Curet Myriam (EVP & Chief Medical Officer) | Sale | 8,000 | 250.06 | 2,000,512 |
| 2022-11-01 | Curet Myriam (EVP & Chief Medical Officer) | Option Ex | 8,000 | 170.44 | 1,363,520 |
| 2022-10-21 | Curet Myriam (EVP & Chief Medical Officer) | Sale | 8,000 | 209.78 | 1,678,240 |
| 2022-10-21 | Curet Myriam (EVP & Chief Medical Officer) | Option Ex | 8,000 | 170.44 | 1,363,520 |
| 2022-10-21 | Guthart Gary S (President & CEO) | Sale | 44,203 | 210.84 | 9,319,627 |
| 2022-10-21 | Guthart Gary S (President & CEO) | Option Ex | 67,500 | 63.25 | 4,269,105 |
| 2022-08-15 | Ladd Amy L (Director) | Sale | 600 | 237.03 | 142,218 |
| 2022-08-03 | Johnson Amal M (Director) | Sale | 6,375 | 238.04 | 1,517,485 |
| 2022-08-03 | Johnson Amal M (Director) | Option Ex | 6,375 | 53.76 | 342,694 |
| 2022-07-27 | Curet Myriam (EVP & Chief Medical Officer) | Sale | 9,000 | 225.00 | 2,025,000 |
| 2022-07-27 | Curet Myriam (EVP & Chief Medical Officer) | Option Ex | 9,000 | 139.52 | 1,255,680 |
| 2022-07-26 | Guthart Gary S (President & CEO) | Sale | 79,412 | 216.30 | 17,177,053 |
| 2022-07-26 | Guthart Gary S (President & CEO) | Option Ex | 126,000 | 57.48 | 7,242,354 |
| 2022-05-11 | Desantis Robert (EVP & Chief Product Officer) | Option Ex | 363 | .00 | 0 |
| 2022-04-26 | Desantis Robert (EVP & Chief Product Officer) | Sale | 1,611 | 253.04 | 407,647 |
| 2022-04-26 | Desantis Robert (EVP & Chief Product Officer) | Option Ex | 1,611 | 211.41 | 340,575 |
| 2022-04-26 | Curet Myriam (EVP & Chief Medical Officer) | Sale | 6,000 | 252.51 | 1,515,060 |
| 2022-04-26 | Curet Myriam (EVP & Chief Medical Officer) | Option Ex | 6,000 | 139.52 | 837,120 |
| 2022-04-22 | Reed Monica P | Option Ex | 555 | .00 | 0 |
| 2022-04-22 | Ladd Amy L | Option Ex | 555 | .00 | 0 |
| 2022-04-22 | Leonard Keith R | Option Ex | 555 | .00 | 0 |
| 2022-04-22 | Johnson Amal M | Option Ex | 555 | .00 | 0 |
| 2022-04-22 | Levy Alan J | Option Ex | 555 | .00 | 0 |
| 2022-04-22 | Barratt Craig H | Option Ex | 753 | .00 | 0 |
| 2022-04-22 | Kania Don R | Option Ex | 555 | .00 | 0 |
| 2022-04-22 | Beery Joseph C | Option Ex | 555 | .00 | 0 |
| 2022-04-22 | Nachtsheim Jami K | Option Ex | 555 | .00 | 0 |
| 2022-04-22 | Rubash Mark J | Option Ex | 555 | .00 | 0 |
| 2022-03-01 | Curet Myriam (EVP & Chief Medical Officer) | Sale | 2,000 | 289.96 | 579,920 |
| 2022-02-28 | Widman Fredrik (VP Corporate Controller) | Option Ex | 852 | .00 | 0 |
| 2022-02-28 | Charlton Henry L (Senior Vice President & Chief) | Option Ex | 1,449 | .00 | 0 |
| 2022-02-28 | Desantis Robert (EVP & Chief Product Officer) | Option Ex | 2,175 | .00 | 0 |
| 2022-02-28 | Andersen Reiter Kara (Sr VP General Counsel & CCO) | Option Ex | 1,128 | .00 | 0 |
| 2022-02-28 | Curet Myriam (EVP & Chief Medical Officer) | Option Ex | 2,256 | .00 | 0 |
| 2022-02-28 | Rosa David J. (Executive Vice President and C) | Option Ex | 2,256 | .00 | 0 |
| 2022-02-28 | Samath Jamie (Chief Financial Officer) | Option Ex | 1,257 | .00 | 0 |
| 2022-02-28 | Guthart Gary S (President & CEO) | Option Ex | 3,867 | .00 | 0 |
| 2022-02-26 | Widman Fredrik (VP Corporate Controller) | Option Ex | 609 | .00 | 0 |
| 2022-02-26 | Charlton Henry L (Senior Vice President & Chief) | Option Ex | 1,284 | .00 | 0 |
| 2022-02-26 | Desantis Robert (EVP & Chief Product Officer) | Option Ex | 1,590 | .00 | 0 |
| 2022-02-26 | Andersen Reiter Kara (Sr VP General Counsel & CCO) | Option Ex | 1,467 | .00 | 0 |
| 2022-02-26 | Curet Myriam (EVP & Chief Medical Officer) | Option Ex | 1,713 | .00 | 0 |
| 2022-02-26 | Rosa David J. (Executive Vice President and C) | Option Ex | 1,713 | .00 | 0 |
| 2022-02-26 | Samath Jamie (Chief Financial Officer) | Option Ex | 1,284 | .00 | 0 |
| 2022-02-26 | Guthart Gary S (President & CEO) | Option Ex | 3,030 | .00 | 0 |
| 2022-02-16 | Curet Myriam (EVP & Chief Medical Officer) | Sale | 2,478 | 289.00 | 716,142 |
| 2022-02-15 | Widman Fredrik (VP Corporate Controller) | Option Ex | 879 | .00 | 0 |
| 2022-02-15 | Charlton Henry L (Senior Vice President & Chief) | Option Ex | 3,186 | .00 | 0 |
| 2022-02-15 | Desantis Robert (EVP & Chief Product Officer) | Option Ex | 4,998 | .00 | 0 |
| 2022-02-15 | Andersen Reiter Kara (Sr VP General Counsel & CCO) | Option Ex | 3,279 | .00 | 0 |
| 2022-02-15 | Curet Myriam (EVP & Chief Medical Officer) | Option Ex | 4,749 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of ISRG listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Intuitive Surgical Inc (symbol ISRG, CIK number 1035267) see the Securities and Exchange Commission (SEC) website.